Products
Tools
Education
$4.34
$4.06
$4.41
$1.39
$186.6M
27.99%
This is a preview of the full version of Prosperse
Checkpoint Therapeutics, a clinical-stage immunotherapy and targeted oncology company, announced that its President and CEO will present a corporate overview at the H.C. Wainwright 26th Annual Global Investment Conference on September 10, 2024.
N/A
Sep 4, 2024
Date: Nov 19, 2024
Date: Nov 14, 2024